<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="utf-8">

  <title>NICE Formulary - FLUTICASONE</title>

  <meta name="X-UA-Compatible" content="IE=edge,chrome=1">
  <meta name="viewport" content="width=device-width, initial-scale=1.0, maximum-scale=1.0">
  <meta name="description" content="">
  <meta name="author" content="NICE - The National Institute of Health and Care Excellence">

  <!--[if lt IE 9]>
  <script src="http://mattonfoot.github.io/NICE.UI/scripts/vendor/html5shiv.js"></script>
  <![endif]-->

  <!-- Le styles -->
  <link rel="stylesheet" href="http://mattonfoot.github.io/NICE.UI/styles/ui.css">

  <!-- Fav and touch icons -->
  <link rel="shortcut icon" href="http://cdn.nice.org.uk/V3/Content/nice/favicon.ico">
  <link rel="apple-touch-icon-precomposed" href="http://cdn.nice.org.uk/V3/Content/nice/favicon-152.png">
  <meta name="msapplication-TileColor" content="#fafafb">
  <meta name="msapplication-TileImage" content="http://cdn.nice.org.uk/V3/Content/nice/favicon-144.png">

  <style>
  .tab-content {
    overflow: auto;
  }
  .tab-content > .tab-pane {
    display: none;
  }
  .tab-content > .active {
    display: block;
  }

  header .nav {
    list-style: decimal inside none;
  }
  header .nav > li {
    display: list-item;
  }
  header .nav > li > a {
    display: block;
    margin: 0;
    padding: 0;
    text-decoration: none;
    color: #01769d;
  }
  header .nav > li > a:hover,
  header .nav > li > a:focus,
  header .nav > li.active > a,
  header .nav > li.active > a:hover,
  header .nav > li.active > a:focus {
    outline: 0;
    color: #08455b;
    background: transparent;
    text-decoration: none;
  }
  header .nav > li > a:hover,
  header .nav > li > a:focus {
    text-decoration: underline;
  }

  [outputclass="title"],
  .title {
    font-size: 19px;
    font-size: 1.9rem;
    line-height: 24px;
    line-height: 2.4rem;
  }

  h3, h4, h5, h6, .title, [outputclass="title"] {
    margin-bottom: 0;
  }

  h1+p, h2+p, h3+p, h4+p, h5+p, h6+p, .title+p, [outputclass="title"]+p {
    margin-top: 0;
  }

  .doses {
    padding-left: 0;
    list-style: none;
  }
  .doses .dose {
    padding-left: 24px;
    padding-left: 2.4rem;
    margin-bottom: 6px;
    margin-bottom: .6rem;
  }
  .doses .adult {
    border-left: 7px solid #346e7f;
  }
  .doses .child {
    border-left: 7px solid #82176F;
  }

  /* DITA symbols */

  ph {
    color: #006;
  }

  tm::before {
    font-size: .8em;
    margin-left: -.2em;
    vertical-align: top;
  }
  tm[tmtype="reg"]::before {
    content: "\00ae";
  }
  tm[tmtype="copy"]::before {
    content: "\00a9";
  }
  tm[tmtype="trade"]::before {
    content: "\2122";
  }

  </style>
</head>

<body id="" class="">
  <header>
    <div class="container">
      <ul class="breadcrumb">
        <li><a href="../">Home</a> <span class="divider glyph-chevron-right"></span></li>
        <li class="active"><a href="../drug/">Drugs</a></li>
      </ul>

      <h1>FLUTICASONE</h1>

        <p><a href="../drugClass/PHP34550.html">CORTICOSTEROIDS (TOPICAL)</a><a href="../drugClass/PHP34648.html">CORTICOSTEROIDS (INTRANASAL)</a><a href="../drugClass/PHP34650.html">CORTICOSTEROIDS (INHALED)</a></p>

      <nav>
        <ul class="nav nav-list">

          <li class="active"><a href="#indicationsAndDoses" data-toggle="tab">Indications and doses</a></li>
          <li><a href="#sideEffects" data-toggle="tab">Side effects</a></li>
          <li><a href="#directionsForAdministration" data-toggle="tab">Administration</a></li>
          <li><a href="#patientAndCarerAdvice" data-toggle="tab">Patient and carer advice</a></li>
          <li><a href="#nationalFunding" data-toggle="tab">National funding/access decisions</a></li>
          <li><a href="#unlicensedUse" data-toggle="tab">Unlicensed use</a></li>
          <li><a href="#exceptionsToLegalCategory" data-toggle="tab">Exceptions to legal category</a></li>
          <li><a href="#medicinalForms" data-toggle="tab">Medicinal forms</a></li>
        </ul>
      </nav>

      <br/>
    </div>
  </header>

  <div class="container">
    <div class="tab-content">

      <section class="tab-pane active" id="indicationsAndDoses">
        <h2>Indications and doses</h2>

        <section class="indicationAndDoseGroups">
          <section class="indicationAndDoseGroup">
            <h4 class="indications">
                <span class="indication">Prophylaxis of asthma</span>,
            </h4>
            <p class="specificity"><span class="route">By inhalation of nebulised suspension</span></p>
            <ul class="doses">
              <li class="dose adult"><strong>For adults </strong><br/>
                Initially 100&#8211;500 micrograms twice daily (max. per dose 1 mg twice daily), dose may be increased according to severity of asthma. Doses above 500 micrograms twice daily initiated by a specialist.</li>
              <li class="dose adult"><strong>For adults </strong><br/>
                Initially 100&#8211;500 micrograms twice daily (max. per dose 1 mg twice daily), dose may be increased according to severity of asthma. Doses above 500 micrograms twice daily initiated by a specialist.</li>
              <li class="dose adult"><strong>For adults </strong><br/>
                0.5&#8211;2 mg twice daily.</li>
              <li class="dose child"><strong>For children 5&#8211;15 years</strong><br/>
                Initially 50&#8211;100 micrograms twice daily (max. per dose 200 micrograms twice daily), dose to be adjusted as necessary.</li>
              <li class="dose child"><strong>For children 16&#8211;17 years</strong><br/>
                Initially 100&#8211;500 micrograms twice daily (max. per dose 1 mg twice daily), dose may be increased according to severity of asthma. Doses above 500 micrograms twice daily initiated by a specialist.</li>
              <li class="dose child"><strong>For children 4&#8211;15 years</strong><br/>
                Initially 50&#8211;100 micrograms twice daily (max. per dose 200 micrograms twice daily), dose to be adjusted as necessary.</li>
              <li class="dose child"><strong>For children 16&#8211;17 years</strong><br/>
                Initially 100&#8211;500 micrograms twice daily (max. per dose 1 mg twice daily), dose may be increased according to severity of asthma. Doses above 500 micrograms twice daily initiated by a specialist.</li>
              <li class="dose child"><strong>For children 4&#8211;15 years</strong><br/>
                1 mg twice daily.</li>
              <li class="dose child"><strong>For children 16&#8211;17 years</strong><br/>
                0.5&#8211;2 mg twice daily.</li>
            </ul>
          </section>
          <section class="indicationAndDoseGroup">
            <h4 class="indications">
                <span class="indication">Prophylaxis and treatment of allergic rhinitis and perennial rhinitis</span>,
            </h4>
            <p class="specificity"><span class="route">By intranasal administration using nasal spray</span></p>
            <ul class="doses">
              <li class="dose adult"><strong>For adults </strong><br/>
                100 micrograms once daily, to be administered into each nostril preferably in the morning, increased if necessary to 100 micrograms twice daily; reduced to 50 micrograms once daily, dose to be administered into each nostril, dose to be reduced when control achieved.</li>
              <li class="dose child"><strong>For children 4&#8211;11 years</strong><br/>
                50 micrograms once daily, to be administered into each nostril preferably in the morning, increased if necessary to 50 micrograms twice daily.</li>
              <li class="dose child"><strong>For children 12&#8211;17 years</strong><br/>
                100 micrograms once daily, to be administered into each nostril preferably in the morning, increased if necessary to 100 micrograms twice daily; reduced to 50 micrograms once daily, dose to be administered into each nostril, dose to be reduced when control achieved.</li>
            </ul>
          </section>
          <section class="indicationAndDoseGroup">
            <h4 class="indications">
                <span class="indication">Nasal polyps</span>,
            </h4>
            <p class="specificity"><span class="route">By intranasal administration using nasal drops</span></p>
            <ul class="doses">
              <li class="dose adult"><strong>For adults </strong><br/>
                200 micrograms 1&#8211;2 times a day, to be administered into each nostril, dose of 200 micrograms approximately 6 drops, alternative treatment should be considered if no improvement after 4&#8211;6 weeks.</li>
              <li class="dose child"><strong>For children 16&#8211;17 years</strong><br/>
                200 micrograms 1&#8211;2 times a day, to be administered into each nostril, dose of 200 micrograms approximately 6 drops, alternative treatment should be considered if no improvement after 4&#8211;6 weeks.</li>
            </ul>
          </section>
          <section class="indicationAndDoseGroup">
            <h4 class="indications">
                <span class="indication">Severe inflammatory skin disorders such as dermatitis and eczemas unresponsive to less potent corticosteroids</span>,
                <span class="indication">Psoriasis</span>,
            </h4>
            <p class="specificity"><span class="route">To the skin</span></p>
            <ul class="doses">
              <li class="dose adult"><strong>For adults </strong><br/>
                Apply 1&#8211;2 times a day, to be applied thinly.</li>
              <li class="dose child"><strong>For children 3 months&#8211;17 years</strong><br/>
                Apply 1&#8211;2 times a day, to be applied thinly.</li>
            </ul>
          </section>
        </section>
        
        
        
        
        
            <section class="potency">
              <h3>Potency of preperations</h3>
              <p>Fluticasone cream 0.05%: potent.</p><p>Fluticasone ointment 0.005%: potent.</p>
            </section>
      </section>







      <section class="tab-pane" id="sideEffects">
        <h2>Known side effects</h2>

        
          <h3>Specific side effects</h3>
              <p>
                <strong>notKnown:</strong> arthralgia, dyspepsia,
              </p>
        
            <section class="advice">
                <h3>Nasal ulceration</h3>
              <p>Nasal ulceration occurs commonly with nasal preparations containing fluticasone furoate.</p>
            </section>
        
      </section>

      <section class="tab-pane" id="directionsForAdministration">
        <h2>Directions for administration</h2>

            <section class="directionsForAdministration">
              <h3 class="specificity">When used by <ph outputclass="route">inhalation</ph></h3>
              <p>Fluticasone nebuliser liquid may be diluted with sterile sodium chloride 0.9%. It is not suitable for use in ultrasonic nebulisers.</p>
            </section>
      </section>

      <section class="tab-pane" id="patientAndCarerAdvice">
        <h2>Advice for patients and carers</h2>

            <section class="generalPatientAdvice">
              <h3 class="specificity">When used by <ph outputclass="route">inhalation</ph></h3>
              <p>Patients or carers should be given advice on how to administer all fluticasone inhalations preparations.</p>
            </section>
            <section class="generalPatientAdvice">
              <h3 class="specificity">With <ph outputclass="route">topical</ph> use</h3>
              <p>Patients or carers should be given advice on application of fluticasone creams and ointments,</p>
            </section>
            <section class="patientResources">
              <h3 class="specificity">When used by <ph outputclass="route">inhalation</ph></h3>
              <p>With high doses, a steroid card should be supplied.</p>
            </section>
            <section class="patientResources">
              <h3 class="specificity">In children</h3>
                <p class="title">Medicines for Children leaflet: Fluticasone inhaler for asthma prevention (prophylaxis)</p>
              <p>
            <xref format="html" href="http://www.medicinesforchildren.org.uk/fluticasone-inhaler-for-asthma-prevention">www.medicinesforchildren.org.uk/fluticasone-inhaler-for-asthma-prevention</xref>
            </p>
            </section>
      </section>

      <section class="tab-pane" id="nationalFunding">
        <h2>National funding/access decisions</h2>

      </section>





      <section class="tab-pane" id="unlicensedUse">
        <h2>Unlicensed use</h2>

            <section class="unlicensedUse">
              <h3 class="specificity">With <ph outputclass="route">topical</ph> use in children</h3>
              <p>Not licensed for use in children under 3 months.</p>
            </section>
      </section>








      <section class="tab-pane" id="exceptionsToLegalCategory">
        <h2>Exceptions to legal category</h2>

            <section class="exceptionsToLegalCategory">
              <h3 class="specificity">With <ph outputclass="route">intranasal</ph> use in adults</h3>
              <p>Preparations of fluticasone propionate can be sold to the public for nasal administration (other than by pressurised nasal spray) if supplied for the prevention and treatment of allergic rhinitis in adults over 18 years, subject to max. single dose of 100&#8239;micrograms per nostril, max. daily dose of 200&#8239;micrograms per nostril for max. 3 months, and a pack size of 3&#8239;mg.</p>
            </section>
      </section>


      <section class="tab-pane" id="medicinalForms">
        <h2>Prepared medicinal forms of FLUTICASONE</h2>


            <section class="licensingVariationStatement">
              <p>There can be variation in the licensing of different medicines containing the same drug.</p>
            </section>
        

            <div id="PHP76192"><a href="../medicinalForm/PHP76192.html" data-target="#PHP76192" data-action="load">Pressurised inhalation</a></div>
            <div id="PHP76157"><a href="../medicinalForm/PHP76157.html" data-target="#PHP76157" data-action="load">Inhalation powder</a></div>
            <div id="PHP76163"><a href="../medicinalForm/PHP76163.html" data-target="#PHP76163" data-action="load">Nebuliser liquid</a></div>
            <div id="PHP76150"><a href="../medicinalForm/PHP76150.html" data-target="#PHP76150" data-action="load">Cream</a></div>
            <div id="PHP76170"><a href="../medicinalForm/PHP76170.html" data-target="#PHP76170" data-action="load">Ointment</a></div>
            <div id="PHP76199"><a href="../medicinalForm/PHP76199.html" data-target="#PHP76199" data-action="load">Spray</a></div>
            <div id="PHP76184"><a href="../medicinalForm/PHP76184.html" data-target="#PHP76184" data-action="load">Nasal drops</a></div>
      </section>
    </div>
  </div>

  <script src="http://mattonfoot.github.io/NICE.UI/scripts/vendor/jquery.js"></script>
  <script src="http://cdn.nice.org.uk/V3/Scripts/twitter.bootstrap.js"></script>
  <script src="/content/scripts/NICE.RemoteLoad.js"></script>
</html>
